Checkpoint Therapeutics Statistics
Total Valuation
Danaher has a market cap or net worth of $143.61 billion. The enterprise value is $159.21 billion.
| Market Cap | 143.61B |
| Enterprise Value | 159.21B |
Important Dates
The last earnings date was Tuesday, July 22, 2025, before market open.
| Earnings Date | Jul 22, 2025 |
| Ex-Dividend Date | Jun 27, 2025 |
Share Statistics
Danaher has 716.05 million shares outstanding. The number of shares has decreased by -2.86% in one year.
| Current Share Class | 716.05M |
| Shares Outstanding | 716.05M |
| Shares Change (YoY) | -2.86% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 10.91% |
| Owned by Institutions (%) | 82.36% |
| Float | 637.22M |
Valuation Ratios
The trailing PE ratio is 42.56 and the forward PE ratio is 24.71. Danaher's PEG ratio is 3.15.
| PE Ratio | 42.56 |
| Forward PE | 24.71 |
| PS Ratio | 6.01 |
| Forward PS | 5.61 |
| PB Ratio | 2.74 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 29.54 |
| P/OCF Ratio | 23.28 |
| PEG Ratio | 3.15 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 21.17, with an EV/FCF ratio of 32.75.
| EV / Earnings | 46.65 |
| EV / Sales | 6.63 |
| EV / EBITDA | 21.17 |
| EV / EBIT | 31.02 |
| EV / FCF | 32.75 |
Financial Position
The company has a current ratio of 1.62, with a Debt / Equity ratio of 0.35.
| Current Ratio | 1.62 |
| Quick Ratio | 1.10 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 2.37 |
| Debt / FCF | 3.82 |
| Interest Coverage | 17.64 |
Financial Efficiency
Return on equity (ROE) is 6.68% and return on invested capital (ROIC) is 4.62%.
| Return on Equity (ROE) | 6.68% |
| Return on Assets (ROA) | 4.01% |
| Return on Invested Capital (ROIC) | 4.62% |
| Return on Capital Employed (ROCE) | 6.86% |
| Revenue Per Employee | $381,159 |
| Profits Per Employee | $54,175 |
| Employee Count | 63,000 |
| Asset Turnover | 0.30 |
| Inventory Turnover | 3.61 |
Taxes
In the past 12 months, Danaher has paid $663.00 million in taxes.
| Income Tax | 663.00M |
| Effective Tax Rate | 16.27% |
Stock Price Statistics
The stock price has decreased by -23.83% in the last 52 weeks. The beta is 0.76, so Danaher's price volatility has been lower than the market average.
| Beta (5Y) | 0.76 |
| 52-Week Price Change | -23.83% |
| 50-Day Moving Average | 198.11 |
| 200-Day Moving Average | 213.15 |
| Relative Strength Index (RSI) | 52.68 |
| Average Volume (20 Days) | 4,852,731 |
Short Selling Information
The latest short interest is 7.84 million, so 1.10% of the outstanding shares have been sold short.
| Short Interest | 7.84M |
| Short Previous Month | 7.75M |
| Short % of Shares Out | 1.10% |
| Short % of Float | 1.23% |
| Short Ratio (days to cover) | 2.08 |
Income Statement
In the last 12 months, Danaher had revenue of $24.01 billion and earned $3.41 billion in profits. Earnings per share was $4.71.
| Revenue | 24.01B |
| Gross Profit | 14.34B |
| Operating Income | 5.13B |
| Pretax Income | 4.75B |
| Net Income | 3.41B |
| EBITDA | 7.52B |
| EBIT | 5.13B |
| Earnings Per Share (EPS) | $4.71 |
Balance Sheet
The company has $2.96 billion in cash and $18.56 billion in debt, giving a net cash position of -$15.60 billion or -$21.78 per share.
| Cash & Cash Equivalents | 2.96B |
| Total Debt | 18.56B |
| Net Cash | -15.60B |
| Net Cash Per Share | -$21.78 |
| Equity (Book Value) | 52.34B |
| Book Value Per Share | 73.10 |
| Working Capital | 4.21B |
Cash Flow
In the last 12 months, operating cash flow was $6.17 billion and capital expenditures -$1.31 billion, giving a free cash flow of $4.86 billion.
| Operating Cash Flow | 6.17B |
| Capital Expenditures | -1.31B |
| Free Cash Flow | 4.86B |
| FCF Per Share | $6.79 |
Margins
Gross margin is 59.72%, with operating and profit margins of 21.38% and 14.21%.
| Gross Margin | 59.72% |
| Operating Margin | 21.38% |
| Pretax Margin | 16.97% |
| Profit Margin | 14.21% |
| EBITDA Margin | 31.32% |
| EBIT Margin | 21.38% |
| FCF Margin | 20.25% |
Dividends & Yields
This stock pays an annual dividend of $1.28, which amounts to a dividend yield of 0.64%.
| Dividend Per Share | $1.28 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | 12.38% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 25.04% |
| Buyback Yield | 2.86% |
| Shareholder Yield | 3.50% |
| Earnings Yield | 2.38% |
| FCF Yield | 3.39% |
Analyst Forecast
The average price target for Danaher is $260.29, which is 29.78% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $260.29 |
| Price Target Difference | 29.78% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 6.08% |
| EPS Growth Forecast (5Y) | 16.81% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on June 14, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 14, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Danaher has an Altman Z-Score of 4.76 and a Piotroski F-Score of 6.
| Altman Z-Score | 4.76 |
| Piotroski F-Score | 6 |